James Cassella resumes & CV records
Resumes
James Cassella
Location:
Dallas/Fort Worth Area
Industry:
Information Technology and Services
James L Cassella, 782304 Broadoak Way, Colleyville, TX 76034
James Cassella Phones & Addresses
2304 Broadoak Way, Colleyville, TX 76034
918 40Th St, Austin, TX 78751 512-4538039
Madison, CT
Irving, TX
Grapevine, TX
Social networks
James L Cassella
Linkedin
Work
Position:
Food Preparation and Serving Related Occupations
Education
Degree:
High school graduate or higher
Emails
Industries
Information Technology and Services
Mentions for James L Cassella
Publications & IP owners
Wikipedia
East Rutherford New Jersey
Incumbent Republican James L. Cassella (1275 votes) won re-election to a fourth term as mayor over Democratic challenger Gary M. Viccaro (605). ...
Us Patents
Combination Use Of Acetylcholinesterase Inhibitors And Gabaa Inverse Agonists For The Treatment Of Cognitive Disorders
US Patent:
2002015, Oct 17, 2002
Filed:
Oct 12, 2001
Appl. No.:
09/976347
Inventors:
Anabella Villalobos - Niantic CT, US
James Cassella - Guilford CT, US
Lavanya Rajachandran - Wallingford CT, US
James Cassella - Guilford CT, US
Lavanya Rajachandran - Wallingford CT, US
International Classification:
A61K031/195
US Classification:
514/561000
Abstract:
This invention provides a composition for treating a cognitive disorder, which comprises an acetylcholinesterase inhibitor, and a GABAinverse agonist selected from a compound of the formula where X and Y are as defined herein.
Combination Use Of Acetylcholinesterase Inhibitors And Gabaa Inverse Agonists For The Treatment Of Cognitive Disorders
US Patent:
2005000, Jan 13, 2005
Filed:
Aug 6, 2004
Appl. No.:
10/912993
Inventors:
Anabella Villalobos - Niantic CT, US
James Cassella - Guilford CT, US
Lavanya Rajachandran - Wallingford CT, US
James Cassella - Guilford CT, US
Lavanya Rajachandran - Wallingford CT, US
International Classification:
A61K031/4745
US Classification:
514300000
Abstract:
This invention provides a composition for treating a cognitive disorder, which comprises an acetylcholinesterase inhibitor, and a GABAinverse agonist selected from a compound of the formula where X and Y are as defined herein.
Nicotine Salt With Meta-Salicylic Acid And Applications Therein
US Patent:
2022040, Dec 22, 2022
Filed:
Aug 22, 2022
Appl. No.:
17/893147
Inventors:
- Mountain View CA, US
James CASSELLA - Essex CT, US
James CASSELLA - Essex CT, US
International Classification:
A61K 31/465
A61M 15/06
A61K 9/00
A61K 31/60
A61M 5/00
A61M 11/04
A61M 15/00
A61M 35/00
A61M 37/00
C07D 401/04
A24B 15/167
A61M 31/00
C07C 63/08
H05B 1/02
C07C 65/10
A61M 15/06
A61K 9/00
A61K 31/60
A61M 5/00
A61M 11/04
A61M 15/00
A61M 35/00
A61M 37/00
C07D 401/04
A24B 15/167
A61M 31/00
C07C 63/08
H05B 1/02
C07C 65/10
Abstract:
The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.
Treatment Of Hair Loss Disorders With Deuterated Jak Inhibitors
US Patent:
2020022, Jul 16, 2020
Filed:
Dec 5, 2019
Appl. No.:
16/704402
Inventors:
- Lexington MA, US
James V. Cassella - Essex CT, US
Philip B. Graham - Boston MA, US
Virginia Braman - Winchester MA, US
Vinita Uttamsingh - Chestnut Hill MA, US
Jana Von Hehn - Newton MA, US
Colleen E. Hamilton - Carlisle MA, US
James V. Cassella - Essex CT, US
Philip B. Graham - Boston MA, US
Virginia Braman - Winchester MA, US
Vinita Uttamsingh - Chestnut Hill MA, US
Jana Von Hehn - Newton MA, US
Colleen E. Hamilton - Carlisle MA, US
International Classification:
A61K 31/519
A61K 9/20
A61P 17/14
A61K 9/00
A61K 9/20
A61P 17/14
A61K 9/00
Abstract:
Disclosed is a method of treating in a subject hair loss disorders that are beneficially treated by administering a JAK1 and/or JAK2 inhibitor. The method comprises administering to the subject an amount in the range of about 4 mg to about 50 mg of Compound (I):or a pharmaceutically acceptable salt thereof. This invention also provides compositions comprising Compound (I) and the use of such compositions in the described methods.
Nicotine Salt With Meta-Salicylic Acid And Applications Therein
US Patent:
2019020, Jul 11, 2019
Filed:
Dec 28, 2018
Appl. No.:
16/235675
Inventors:
- Mountain View CA, US
James CASSELLA - Essex CT, US
James CASSELLA - Essex CT, US
International Classification:
A61K 31/465
A61M 31/00
A61K 9/00
A61M 5/00
A61M 11/04
A61M 15/00
A61M 35/00
A61M 37/00
A61K 31/60
A61M 15/06
C07D 401/04
C07C 63/08
H05B 1/02
C07C 65/10
A24F 47/00
A24B 15/16
A61M 31/00
A61K 9/00
A61M 5/00
A61M 11/04
A61M 15/00
A61M 35/00
A61M 37/00
A61K 31/60
A61M 15/06
C07D 401/04
C07C 63/08
H05B 1/02
C07C 65/10
A24F 47/00
A24B 15/16
Abstract:
The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.
Treatment Of Hair Loss Disorders With Deuterated Jak Inhibitors
US Patent:
2019016, May 30, 2019
Filed:
May 4, 2017
Appl. No.:
16/098338
Inventors:
- Lexington MA, US
James V. Cassella - Essex CT, US
Philip B. Graham - Boston MA, US
Virginia Braman - Winchester MA, US
Vinita Uttamsingh - Chestnut Hill MA, US
Jana Von Hehn - Newton MA, US
Colleen E. Hamilton - Carlisle MA, US
James V. Cassella - Essex CT, US
Philip B. Graham - Boston MA, US
Virginia Braman - Winchester MA, US
Vinita Uttamsingh - Chestnut Hill MA, US
Jana Von Hehn - Newton MA, US
Colleen E. Hamilton - Carlisle MA, US
International Classification:
A61K 31/519
A61P 17/14
A61K 9/00
A61K 9/20
A61P 17/14
A61K 9/00
A61K 9/20
Abstract:
Disclosed is a method of treating in a subject hair loss disorders that are beneficially treated by administering a JAK1 and/or JAK2 inhibitor. The method comprises administering to the subject an amount in the range of about 4 mg to about 50 mg of Compound (I), or a pharmaceutically acceptable salt thereof. This invention also provides compositions comprising Compound (I) and the use of such compositions in the described methods.
Nicotine Salt With Meta-Salicylic Acid And Applications Therein
US Patent:
2018002, Jan 25, 2018
Filed:
Aug 7, 2017
Appl. No.:
15/671129
Inventors:
- Mountain View CA, US
James CASSELLA - Essex CT, US
James CASSELLA - Essex CT, US
International Classification:
A61K 31/465
A61M 15/06
C07C 65/10
C07D 401/04
A61M 15/00
A24B 15/16
H05B 1/02
A24F 47/00
A61K 9/00
C07C 63/08
A61K 31/60
A61M 5/00
A61M 11/04
A61M 37/00
A61M 35/00
A61M 11/00
A61M 16/00
A61K 9/70
A61M 15/06
C07C 65/10
C07D 401/04
A61M 15/00
A24B 15/16
H05B 1/02
A24F 47/00
A61K 9/00
C07C 63/08
A61K 31/60
A61M 5/00
A61M 11/04
A61M 37/00
A61M 35/00
A61M 11/00
A61M 16/00
A61K 9/70
Abstract:
The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.
Nicotine Salt With Meta-Salicylic Acid And Applications Therein
US Patent:
2016032, Nov 10, 2016
Filed:
Jul 19, 2016
Appl. No.:
15/213580
Inventors:
- Mountain View CA, US
James CASSELLA - Essex CT, US
James CASSELLA - Essex CT, US
International Classification:
A61K 31/465
A24F 47/00
C07C 65/10
A61M 15/06
A61K 9/00
C07D 401/04
A24F 47/00
C07C 65/10
A61M 15/06
A61K 9/00
C07D 401/04
Abstract:
The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.